Predictive Factors And Long-Term Visual Outcomes After Anti-Vascular Endothelial Growth Factor Treatment Of Retinal Angiomatous Proliferation
Maiko Maruyama-Inoue, Shimpei Sato, Shin Yamane, Kazuaki Kadonosono Department of Ophthalmology, Yokohama City University Medical Center, Yokohama, JapanCorrespondence: Maiko Maruyama-InoueDepartment of Ophthalmology, Yokohama City University Medical Center, 4-57 Urafune-cho, Minami-ku, Yokohama, Ka...
Main Authors: | Maruyama-Inoue M, Sato S, Yamane S, Kadonosono K |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2019-10-01
|
Series: | Clinical Ophthalmology |
Subjects: | |
Online Access: | https://www.dovepress.com/predictive-factors-and-long-term-visual-outcomes-after-anti-vascular-e-peer-reviewed-article-OPTH |
Similar Items
-
Ranibizumab in monotherapy and combined with photodynamic therapy for retinal angiomatous proliferation
by: Arias L, et al.
Published: (2016-05-01) -
Successful Treatment of Retinal Angiomatous Proliferation with Intravitreal Triamcinolone and Ranibizumab Injections in a 67-Year-Old Male
by: Adnaan Haq, et al.
Published: (2014-11-01) -
Short-term efficacy of intravitreal Aflibercept injections for retinal angiomatous proliferation
by: Hung-Da Chou, et al.
Published: (2017-06-01) -
Advances in the treatment of retinal angiomatous proliferation
by: Wang-Yi Fang, et al.
Published: (2017-12-01) -
Retinal function determined by flicker ERGs before and soon after intravitreal injection of anti-VEGF agents
by: Gaku Terauchi, et al.
Published: (2019-06-01)